Videos

Hyman Muss, MD, details his best practices for delivering effective end-of-life care for patients with breast cancer.

Benjamin Miron, MD, discusses the course of treatment he would take for a patient with advanced urothelial carcinoma with spinal and liver metastasis.

Kelly Hunt, MD, discusses the practice of axillary reverse mapping in the prevention of lymphedema for patients with breast cancer.

At 2023 ESMO Targeted Anticancer Therapies Congress, Alison Schram, MD, discusses the class II/III alterations of BRAF inhibitors.

Dr Hyman Muss offers his insights on how metronomic chemotherapy can fit into the treatment paradigm for patients with breast cancer.

Arielle Medford, MD, outlines the steps she would take to treat a patient with ER-negative, PR-negative, HER2-positive breast cancer.

Koen W. van Besien, MD, recaps a debate in which he argued that patients with acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS) and TP53 mutations should undergo allogeneic stem cell transplantation.

Daniel Petrylak, MD, discusses an abstract presented at 2023 ASCO Genitourinary Cancers Symposium, evaluating pembrolizumab plus docetaxel for metastatic castration-resistant prostate cancer.

Drs Wei Shen Tan and Ashish Kamat discuss the treatment options for a patient who develops disease recurrence following treatment with BCG and who is unwilling to undergo radical cystectomy.

At the 2023 ASCO Genitourinary Cancers Symposium, Neeraj Agarwal, MD, presented results from a phase 3 trial evaluating enzalutamide plus talazoparib vs enzalutamide plus placebo for patients with metastatic castration-resistant prostate...